Societal expectations can create barriers that prevent men from seeking out the mental, physical, and sexual help they need. Clinicians can help break these down.

They keep costs low by prescribing generic versions of brand-name drugs, like Viagra and Cialis, that work just as well as ...

Hims & Hers Health, Inc. (NYSE:HIMS) investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beating ...

Additionally, some under-the-weather employees will feel well enough to get some work done if they can do so from home. 5. Telecommuting eliminates unnecessary meetings. Most business owners ...

At-home careers and WFH jobs are more popular than ever before, with many companies supporting work-life balance. And FlexJobs is here to get you connected with a database full of legitimate work-from ...

Hims & Hers Health, Inc. reported record Q3 '24 ... Before buying or selling any stock, you should do your own research and reach your own conclusion or consult a financial advisor.

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025. "We have already confirmed a core supplier ...

At this time, I would like to welcome everyone to Hims & Hers Third Quarter 2024 Earnings ... Standard doses will work for many patients, however, given the diversity of obesity challenges across ...

Hims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 32 cents in third-quarter 2024 against the year-ago period’s loss of 4 cents per share. The metric was in line with the Zacks ...

Direct-to-consumer telehealth company Hims & Hers is defending its sale of compounded glucagon-like peptide agonists, or GLP-1s, even as shortages of the name brand weight loss medications are waning.